Login to Your Account



Japan's MHLW OKs manufacture of Takeda's influenza vaccine

By Cornelia Zou
Staff Writer

Wednesday, April 9, 2014

HONG KONG – Takeda Pharmaceutical Co. has the green light to manufacture and market its cell cultured influenza vaccines co-developed with Baxter International Inc. The approval is yet another step in Japan's push to boost its influenza preparedness.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription